Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
A multi-omic analysis of MCF10A cells provides a resource for integrative assessment of ligand-mediated molecular and phenotypic responses.
Commun Biol. 2022 Oct 7;5(1):1066. doi: 10.1038/s42003-022-03975-9.
Commun Biol. 2022.
PMID: 36207580
Free PMC article.
Pathway-Enriched Gene Signature Associated with 53BP1 Response to PARP Inhibition in Triple-Negative Breast Cancer.
Hassan S, Esch A, Liby T, Gray JW, Heiser LM.
Hassan S, et al.
Mol Cancer Ther. 2017 Dec;16(12):2892-2901. doi: 10.1158/1535-7163.MCT-17-0170. Epub 2017 Sep 27.
Mol Cancer Ther. 2017.
PMID: 28958991
Free PMC article.
Item in Clipboard
Microenvironment-Mediated Mechanisms of Resistance to HER2 Inhibitors Differ between HER2+ Breast Cancer Subtypes.
Watson SS, Dane M, Chin K, Tatarova Z, Liu M, Liby T, Thompson W, Smith R, Nederlof M, Bucher E, Kilburn D, Whitman M, Sudar D, Mills GB, Heiser LM, Jonas O, Gray JW, Korkola JE.
Watson SS, et al.
Cell Syst. 2018 Mar 28;6(3):329-342.e6. doi: 10.1016/j.cels.2018.02.001. Epub 2018 Mar 14.
Cell Syst. 2018.
PMID: 29550255
Free PMC article.
Item in Clipboard
Enzalutamide response in a panel of prostate cancer cell lines reveals a role for glucocorticoid receptor in enzalutamide resistant disease.
Smith R, Liu M, Liby T, Bayani N, Bucher E, Chiotti K, Derrick D, Chauchereau A, Heiser L, Alumkal J, Feiler H, Carroll P, Korkola JE.
Smith R, et al.
Sci Rep. 2020 Dec 10;10(1):21750. doi: 10.1038/s41598-020-78798-x.
Sci Rep. 2020.
PMID: 33303959
Free PMC article.
Item in Clipboard
Sensitivity to targeted therapy differs between HER2-amplified breast cancer cells harboring kinase and helical domain mutations in PIK3CA.
Garay JP, Smith R, Devlin K, Hollern DP, Liby T, Liu M, Boddapati S, Watson SS, Esch A, Zheng T, Thompson W, Babcock D, Kwon S, Chin K, Heiser L, Gray JW, Korkola JE.
Garay JP, et al.
Breast Cancer Res. 2021 Aug 3;23(1):81. doi: 10.1186/s13058-021-01457-0.
Breast Cancer Res. 2021.
PMID: 34344439
Free PMC article.
Item in Clipboard
INHBA is a mediator of aggressive tumor behavior in HER2+ basal breast cancer.
Liu M, Smith R, Liby T, Chiotti K, López CS, Korkola JE.
Liu M, et al.
Breast Cancer Res. 2022 Mar 5;24(1):18. doi: 10.1186/s13058-022-01512-4.
Breast Cancer Res. 2022.
PMID: 35248133
Free PMC article.
Item in Clipboard
Analysis and modeling of cancer drug responses using cell cycle phase-specific rate effects.
Gross SM, Mohammadi F, Sanchez-Aguila C, Zhan PJ, Liby TA, Dane MA, Meyer AS, Heiser LM.
Gross SM, et al. Among authors: liby ta.
Nat Commun. 2023 Jun 10;14(1):3450. doi: 10.1038/s41467-023-39122-z.
Nat Commun. 2023.
PMID: 37301933
Free PMC article.
Item in Clipboard
Akt3 controls vascular endothelial growth factor secretion and angiogenesis in ovarian cancer cells.
Liby TA, Spyropoulos P, Buff Lindner H, Eldridge J, Beeson C, Hsu T, Muise-Helmericks RC.
Liby TA, et al.
Int J Cancer. 2012 Feb 1;130(3):532-43. doi: 10.1002/ijc.26010. Epub 2011 Apr 20.
Int J Cancer. 2012.
PMID: 21351097
Free PMC article.
Item in Clipboard
Cite
Cite